Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -242.00M | -232.00M | 36.00M | 434.00M | 373.00M |
| Total Depreciation and Amortization | 663.00M | 649.00M | 635.00M | 627.00M | 618.00M |
| Total Amortization of Deferred Charges | 28.00M | 31.00M | 35.00M | 37.00M | 39.00M |
| Total Other Non-Cash Items | 55.00M | 13.00M | -7.00M | -645.00M | -584.00M |
| Change in Net Operating Assets | 73.00M | 99.00M | -70.00M | 119.00M | 89.00M |
| Cash from Operations | 577.00M | 560.00M | 629.00M | 572.00M | 535.00M |
| Capital Expenditure | -262.00M | -276.00M | -261.00M | -211.00M | -188.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -41.00M | -41.00M | -41.00M |
| Divestitures | 0.00 | 9.00M | 9.00M | 1.30B | 1.30B |
| Other Investing Activities | -19.00M | -12.00M | -12.00M | -11.00M | -11.00M |
| Cash from Investing | -281.00M | -279.00M | -305.00M | 1.04B | 1.06B |
| Total Debt Issued | 2.40B | 2.65B | 540.00M | 600.00M | 720.00M |
| Total Debt Repaid | -2.76B | -2.92B | -850.00M | -2.34B | -2.11B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -34.00M | -13.00M | -13.00M | -13.00M | -13.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.00M | 11.00M | 34.00M | 281.00M | -10.00M |
| Cash from Financing | -392.00M | -275.00M | -289.00M | -1.48B | -1.41B |
| Foreign Exchange rate Adjustments | 37.00M | 71.00M | -20.00M | -13.00M | -43.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.00M | 77.00M | 15.00M | 123.00M | 142.00M |